BIOFIL CHEMICALS & PHARMACEUTICALS LTD.

NSE : BIOFILCHEMBSE : 524396ISIN CODE : INE829A01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE70.95-1.71 (-2.35 %)
PREV CLOSE ( ) 72.66
OPEN PRICE ( ) 71.15
BID PRICE (QTY) 70.96 (84)
OFFER PRICE (QTY) 71.29 (2)
VOLUME 9145
TODAY'S LOW / HIGH ( )69.50 73.45
52 WK LOW / HIGH ( )41.01 78.8
NSE71.20-1.4 (-1.93 %)
PREV CLOSE( ) 72.60
OPEN PRICE ( ) 73.65
BID PRICE (QTY) 71.10 (6)
OFFER PRICE (QTY) 71.20 (234)
VOLUME 46800
TODAY'S LOW / HIGH( ) 69.55 73.65
52 WK LOW / HIGH ( )41.3 79
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.